Emerging Biologics are the fastest growing segment fueling the growth of Interstitial Lung Disease Market

 

The global Interstitial Lung Disease Market is estimated to be valued at US$ 1790.83 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Interstitial lung diseases (ILDs) are a group of lung disorders affecting the interstitium (the tissue and space around the air sacs of the lungs). Common symptoms include dry cough and shortness of breath on exertion. ILDs are often progressive and can lead to severe respiratory failure. The treatment of ILDs aims to slow disease progression and relieve symptoms.

Market key trends:

One of the key trends seen in the Interstitial Lung Disease market is the increasing focus on development of biologics. Emerging biologics target specific pathways implicated in the pathogenesis of ILD and show promising preclinical and early clinical trial results. Compared to generic drugs, biologics have novel mechanisms of action and ability to selectively modulate certain pathways. They are thus expected to revolutionize the treatment landscape of ILDs by arresting or reversing disease progression with fewer side effects. Leading drug makers are investing heavily in development of new biologics for fibrotic lung diseases like idiopathic pulmonary fibrosis and are conducting large phase III trials. If successful, biologics will capture a major share of the lucrative ILD market worldwide.

Segment Analysis

The Global Interstitial Lung Disease Market Size can be segmented based on type, treatment, and end user. Based on type, the market is segmented into idiopathic pulmonary fibrosis, nonspecific interstitial pneumonia, cryptogenic organizing pneumonia, acute interstitial pneumonia, desert rheumatism associated lung disease and others. Among these, the idiopathic pulmonary fibrosis segment dominated the market in 2023 due to the high prevalence and lack of cure. Based on treatment, the market is divided into drug treatment, oxygen therapy, lung transplant and others. The drug treatment segment holds the largest share as it is the first line therapy for most interstitial lung diseases. Based on end user, the market is bifurcated into hospitals, specialty clinics and research & academic institutes. Hospitals dominated the segment due to availability of advanced treatment facilities.

Key Takeaways

The global interstitial lung disease market is expected to witness high growth, exhibiting CAGR of 6.5% over the forecast period, due to increasing ageing population and rising awareness about lung diseases.

Regional analysis

North America dominated the interstitial lung disease market in 2023 due to increasing prevalence of chronic respiratory diseases, developed healthcare infrastructure and availability of sophisticated treatments in the region. Asia Pacific is expected to grow at the fastest rate during the forecast period owing to rising pollution levels, smoking rates and improving healthcare facilities.

Key players
Key players operating in the interstitial lung disease market are MSD (Merck), Liminal Biosciences, Glenmark Pharma, J.B. Chemicals & Pharmaceuticals, Boehringer Ingelhim International GmbH, F. Hoffmann-La Roche Ltd, Inc., and Cipla. MSD is the market leader with wide product portfolio and global presence. Liminal Biosciences is emerging as prominent player focusing on orphan lung diseases.

Read Our More Blogs : https://www.rapidwebwire.com/interstitial-lung-disease-market-size-share-analysis-2023-2030/

Comments

Post a Comment

Popular posts from this blog

Macrophage Marker Market Poised to Grow at a Robust Pace Due to Rising Demand in Medical Diagnostics

Image
  The macrophage marker market has witnessed significant growth in recent years owing to the growing applications of macrophage markers in medical diagnostics. Macrophage markers are proteins or cell surface receptors that are expressed by macrophages and are used to identify and study macrophages and their functions. Some of the key macrophage markers include CD14, CD68, CD163, CD206, and LAMP-3. These markers play a vital role in studying the functions of macrophages in various diseases like cancer, inflammatory disorders, and infectious diseases. The global macrophage marker market is estimated to be valued at US$ 295.15 million in 2024 and is expected to exhibit a CAGR of 2.7% over the forecast period of 2024-2030. The growing prevalence of various chronic and infectious diseases and increase in R&D spending for drug discovery are some of the key factors driving the demand for macrophage markers in recent years. Macrophage markers help in evaluating disease progression, d...
Read more

The global Cancer Diagnostics Market is growing at an accelerated pace

Image
  Cancer diagnostics involve various tests and procedures used to detect different types of cancers as early as possible to help improve treatment outcomes. From simple blood tests and imaging scans to biopsies and molecular testing, cancer diagnostics help doctors determine if an individual has cancer, where it is located in the body, if it has spread, and other important information. The growing incidences of various cancers like breast, lung, prostate and colorectal cancer globally have increased the demand for advanced and effective diagnostic procedures. Early detection is critical for cancers to treat them effectively and improve chances of survival. The global Cancer Diagnostics Market is estimated to be valued at US$ 59.1 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Immunohistochemistry is one of the key diagnostic trends gaining popu...
Read more

The Global Boat Accumulator Market Growth Is Accelerated By Increasing Consumer Spending

Image
  Boat accumulators or batteries are sealed lead acid batteries that provide starting power and deep cycle power for boats. They are essential for powering marine electrical systems, motors, navigation lights, bilge pumps and other onboard appliances. The growing marine tourism and recreational boating activities have increased the demand for boats and yachts over the years. This has propelled the boat accumulator market. The global Boat Accumulator Market is estimated to be valued at US$ 266.66 Mn in 2023 and is expected to exhibit a CAGR of 2.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Increasing consumer spending on recreational boating activities has been a major driver for the boat accumulator market over the past decade. The number of recreational boats sold globally has increased steadily with the rise in disposable incomes and leisure time among consumers. Countries like the United S...
Read more